P-500. Awareness and preferences for every 2 month long-acting injectable HIV Pre-Exposure Prophylaxis (PrEP) versus daily oral PrEP among cisgender women in the United States and the Dominican Republic
Metzner A, Oglesby A, O’Rourke A, Galai N, Karver T, Davis W, Scott R, Moriarty P, Taggart T, Barrington C, Gomez H, Perez M, Donastorg Y, Kerrigan D. P-500. Awareness and preferences for every 2 month long-acting injectable HIV Pre-Exposure Prophylaxis (PrEP) versus daily oral PrEP among cisgender women in the United States and the Dominican Republic. Open Forum Infectious Diseases 2025, 12: ofae631.699. PMCID: PMC11779361, DOI: 10.1093/ofid/ofae631.699.Peer-Reviewed Original ResearchHIV pre-exposure prophylaxisFemale sex workersOral PrEPPre-exposure prophylaxisLAI-PrEPDaily oral PrEPNumbers of sex partnersReproductive health clinicsSexual health clinicsHealth clinicsCisgender womenAcquired HIVHIV acquisitionLong-actingDaily pillInjectable PrEPPrEP clinicPrimary care clinicsPrEP useLatina ethnicityCondom useHIV knowledgeSex partnersPrEP awarenessHIV
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply